| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―May―25 |
A brief overview on COVID-19 and its comparison with SARS, MERS, and H1N1 |
Saeed Reza Hormozi Jangi |
| 2 |
[GO] |
2023―May―24 |
Natural Polyphenols of Pomegranate and Black Tea Juices can Combat COVID-19 through their SARS-CoV-2 3C-like Protease-inhibitory Activity |
Saeed Reza Hormozi Jangi |
| 3 |
[GO] |
2023―May―24 |
[Review] Sarcopenia in Coronavirus Disease (COVID-19): All to Know from Basic to Nutritional Interventions from Hospital to Home |
Mohammed Reza Shadmand Foumani Moghadam, Sajedeh Jandari, Amirmohammad Vaezi, Reza Rezvani |
| 4 |
[GO] |
2023―May―23 |
Supply Chain and Digital Transformation of the Automotive Manufacturing Company during the COVID-19 Pandemic: A Case Study of PT. X |
Andre Susilo Handojo Putro, Adhi Setyo Santoso |
| 5 |
[GO] |
2023―May―22 |
Evolution of new variants of SARS-CoV-2 during the pandemic: mutation-limited or selection-limited? |
Srashti Bajpai, Milind Watve |
| 6 |
[GO] |
2023―May―11 |
Implementation of e-learning during COVID-19 |
Mitja Tanjga |
| 7 |
[GO] |
2023―May―07 |
Review of: "Online learning during the COVID-19 pandemic, lessons learned and what’s next?" |
Angelina Kirkova-Bogdanova |
| 8 |
[GO] |
2023―Feb―24 |
Review of: "Psycho-Emotional Impact of the First Wave of the COVID-19 Pandemic in Health Care Workers of a Large COVID-19 European Hospital." |
Amy Menard |
| 9 |
[GO] |
2023―Feb―20 |
Review of: "African languages and COVID-19: Translations and interpretations of COVID-19 information in rural communities in Igbo land, Nigeria" |
Phindile A. Dlamini |
| 10 |
[GO] |
2023―Feb―20 |
The two sides of Experienced Crisis: Enabling and preventing Coping strategies during Covid-19 Pandemic |
Athanasia Chalari |
| 11 |
[GO] |
2023―Feb―12 |
Review of: "Polymerized Type I Collagen (Fibroquel) as a treatment for COVID-19, Mexican experience" |
Bensu Karahalil |
| 12 |
[GO] |
2023―Feb―07 |
Child and adolescent self-harm in a pandemic world: Evidence from a decade of data |
David Cawthorpe |
| 13 |
[GO] |
2023―Feb―01 |
COVID-19 and Alzheimer's disease, closely related? |
Luis del Carpio-Orantes, Reynaldo Reich-Sierra |
| 14 |
[GO] |
2023―Feb―01 |
Polymerized Type I Collagen (Fibroquel) as a treatment for COVID-19, Mexican experience |
Luis del Carpio-Orantes, Reynaldo Reich-Sierra |
| 15 |
[GO] |
2023―Feb―01 |
Review of: "Assessing the Impact of COVID-19 on Food Consumption Preferences" |
Zhengqing Zhou |
| 16 |
[GO] |
2023―Jan―27 |
Associations between transactional leadership and safety climate among 314 Pakistani nurses during COVID-19 pandemic: moderating roles of transformational leadership |
Ming Guan |
| 17 |
[GO] |
2023―Jan―27 |
Child and adolescent self-harm in a pandemic world: Evidence from a decade of data |
David Cawthorpe |
| 18 |
[GO] |
2023―Jan―25 |
SARS-COv2 coming of age (and with him both previous successes and new problems) |
Giovanni C Actis, Davide G Ribaldone |
| 19 |
[GO] |
2023―Jan―24 |
A population-based model for rationing COVID-19 vaccine |
David Cawthorpe |
| 20 |
[GO] |
2023―Jan―03 |
[Commentary] The new nucleic acid based COVID-19 vaccines: a glittering achievement, yet disturbed by a black stain that does need to be identified and swept away |
Giovanni C Actis, Davide G Ribaldone |
| 21 |
[GO] |
2022―Dec―22 |
Government Communication and Behavioral Change amidst COVID-19: Role of Awareness and Fear & Panic |
Courage Simon Kofi Dogbe, Wisdom Wise Kwabla Pomegbe, Bylon Abeeku Bamfo, Lawrence Kwabena Hornuvo, Gabriel Sakyi Kwofie |
| 22 |
[GO] |
2022―Dec―15 |
The new nucleic acid based COVID-19 vaccines: a glittering achievement, yet disturbed by a black stain that does need to be identified and swept away |
Giovanni C Actis, Davide G Ribaldone |
| 23 |
[GO] |
2022―Nov―22 |
Comparative analysis between Polymerized Type I Collagen (Fibroquel) and Baricitinib as a potential treatment for moderate-severe COVID-19 in outpatients and inpatients |
Luis del Carpio-Orantes, Sergio García-Méndez, Jesús Salvador Sánchez-Díaz, Ada Lili Rosas-Lozano, Saray Guadalupe Mejía-Ramos, Andrés Aguilar-Silva |
| 24 |
[GO] |
2022―Nov―11 |
On the use of blogging in the classroom of English for Specific Purposes in times of COVID-19 to promote written skills: a collaborative approach |
Ana Ibanez |
| 25 |
[GO] |
2022―Nov―08 |
Evaluation of the impact of the COVID-19 pandemic on nurses |
Bilgehan Irmak, Habip Gedik, Kadriye Kart Yaşar |
| 26 |
[GO] |
2022―Sep―27 |
An insight into the possible benefits of cupping therapy in COVID-19 |
Nooshin Abbasi, Rezvan Najafi, Azam Meyari, Mahdi Biglarkhani |
| 27 |
[GO] |
2022―Jun―03 |
The Environmental Deposition of Severe Acute Respiratory Syndrome Coronavirus 2 in Nosocomial Settings: Role of the Aerosolized Hydrogen Peroxide |
Amani Alnimr |
| 28 |
[GO] |
2022―May―30 |
Role of Nicotine in RAS and Fibrosis Linked to Severe COVID-19 Manifestations |
Ma Xiaoli, Jia Yanfei |
| 29 |
[GO] |
2022―Apr―13 |
The Elimination of the Return line from the HVAC systems due to COVID-19 |
Abdullah Kendoush |
| 30 |
[GO] |
2022―Apr―07 |
Review of: "alitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives" |
Farah Naz |
| 31 |
[GO] |
2022―Mar―28 |
Coronaviruses in Wild Canids: A review of the literature |
Gary Whittaker, Alison Stout |
| 32 |
[GO] |
2022―Mar―22 |
Review of: "The Correlation Between Brain Performance Capacity and COVID-19: A Cross-sectional Survey and Canonical Correlation Analysis" |
Mohamed Saadh |
| 33 |
[GO] |
2022―Feb―24 |
Development of templates to enable countries to apply behavioural science in using global survey data to inform their COVID-19 policies |
Elizabeth Corker, Elena Altieri, Susan Michie, Eloise Adsett |
| 34 |
[GO] |
2022―Jan―27 |
Review of Martinuzzi et al., 2021: “A single dose of COVID-19 mRNA vaccine induces airway immunity in COVID-19 convalescent patients” medRxiv 2021.12.16.21267932 |
Michael Russell |
| 35 |
[GO] |
2022―Jan―14 |
Direct RNA nanopore sequencing of SARS-CoV-2 extracted from critical material from swabs |
Davide Vacca |
| 36 |
[GO] |
2022―Jan―10 |
COVID-19 Pandemic And Surgery: An International Study |
Adriana Cordova, marta nichelini, Francesca Toia |
| 37 |
[GO] |
2021―Nov―15 |
SARS-CoV-2 infection in a fully vaccinated case with newly diagnosed breast cancer: a case report |
anna maria vandone, Manuela Alessio, Veronica Prati, giorgia zucchini, Morena Ciceri, Cinzia Ortega |
| 38 |
[GO] |
2021―Nov―12 |
SARS-CoV-2 infection in a fully vaccinated case with newly diagnosed breast cancer: a case report |
Manuela Alessio |
| 39 |
[GO] |
2021―Aug―13 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 12) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 40 |
[GO] |
2021―Aug―12 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 12) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 41 |
[GO] |
2021―Aug―09 |
Correlations Between COVID-19 Cases, Test Positivity Rates, and Vaccinations in the United States |
Floe Foxon |
| 42 |
[GO] |
2021―Jul―05 |
Review of: "Is it of any positive being COVID-19 positive?: Cross-protection hypothesis" |
Mohammed Jaber |
| 43 |
[GO] |
2021―Jul―05 |
Review of: "Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients" |
Koichiro Kawashima |
| 44 |
[GO] |
2021―Jul―04 |
Review of: "Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial" |
Arindam Basu |
| 45 |
[GO] |
2021―Jul―01 |
Is it of any positive being COVID-19 positive?: Cross-protection hypothesis |
Muath Alser |
| 46 |
[GO] |
2021―Jul―01 |
First report of reduced severe acute respiratory syndrome coronavirus 2 viral load after nasopharyngeal wash with hypertonic water |
Konstantinos Poulas |
| 47 |
[GO] |
2021―Jun―25 |
Review of: "Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients" |
Tawit Suriyo |
| 48 |
[GO] |
2021―Jun―23 |
Enabling countries to apply behavioural science in using global survey data to inform their Covid-19 policies |
Elizabeth Corker, Elena Altieri, Susan Michie |
| 49 |
[GO] |
2021―Jun―21 |
EFFECTIVENESS IN HUMANS OF AN ANTIVIRAL DRUG BASED ON CHOLINERGIC AGONISTS WITH SPECIFIC DESIGN AND ROUTE OF ADMINISTRATION AGAINST COVID-19 SYMPTOMS IN A GROUP OF INFECTED PATIENTS VS. CONTROL GROUP |
orlando Angulo, Hector Fabio Restrepo, José Gabriel León Higuera, Mario Leon Garcia, Fernando Mendive, matteo politi |
| 50 |
[GO] |
2021―Jun―16 |
Journalists with undisclosed conflicts mispresent research on COVID-19, confuse it with tobacco harm reduction and make false allegations about conflicts in a BMJ article |
Konstantinos Farsalinos |
| 51 |
[GO] |
2021―Jun―11 |
Review of: "“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines" |
Maurizio Federico |
| 52 |
[GO] |
2021―Jun―09 |
Journalists criticize research on COVID-19 by confusing it with tobacco harm reduction and by making false allegations about conflicts |
Konstantinos Farsalinos |
| 53 |
[GO] |
2021―Jun―09 |
Journalists criticize research on COVID-19 by confusing it with tobacco harm reduction and by making false allegations about conflicts |
Konstantinos Farsalinos |
| 54 |
[GO] |
2021―May―13 |
Review of: "Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals" |
Chandrasekhar Yadavalli |
| 55 |
[GO] |
2021―May―13 |
Review of: "Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals" |
Chandrasekhar Yadavalli, Anil Mishra |
| 56 |
[GO] |
2021―May―09 |
Review of: "A Potential Therapy for SARS-Cov-2 Virus Deactivation: Carbon Dioxide Management" |
Benjamin Pineda |
| 57 |
[GO] |
2021―May―05 |
Review of: "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons"" |
Helene Banoun |
| 58 |
[GO] |
2021―May―05 |
Review of: "A Potential Therapy for SARS-Cov-2 Virus Deactivation: Carbon Dioxide Management" |
Leo Pruimboom |
| 59 |
[GO] |
2021―May―02 |
Review of: "Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals" |
Peter McIntyre |
| 60 |
[GO] |
2021―May―02 |
Kawa-COVID-19 Storm: Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2? |
Marcos Altable |
| 61 |
[GO] |
2021―Apr―29 |
Review of: "Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study" |
Shrivardhan Dheeman |
| 62 |
[GO] |
2021―Apr―27 |
Review of: "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons" |
Helene Banoun |
| 63 |
[GO] |
2021―Apr―26 |
Adverse events after COVID-19 vaccination: Vector- or spike-induced? |
Konstantinos Poulas |
| 64 |
[GO] |
2021―Apr―25 |
Review of: "Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals" |
Marek Petráš |
| 65 |
[GO] |
2021―Apr―22 |
Review of: "Is SARS-CoV-2 Spike glycoprotein impairing macrophage polarization via α7-nicotinic acetylcholine receptors?" |
Rostyslav Bubnov |
| 66 |
[GO] |
2021―Apr―19 |
Review of: "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant" |
Kenneth Lundstrom |
| 67 |
[GO] |
2021―Apr―19 |
Review of: "Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera" |
Helene Banoun |
| 68 |
[GO] |
2021―Apr―18 |
Review of: "Is SARS-CoV-2 Spike glycoprotein impairing macrophage polarization via α7-nicotinic acetylcholine receptors?" |
Sampurna Chatterjee |
| 69 |
[GO] |
2021―Apr―17 |
Review of: "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant" |
Flaminia Campo |
| 70 |
[GO] |
2021―Apr―07 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)" |
Maria Rosaria Galanti |
| 71 |
[GO] |
2021―Apr―07 |
Review of: "Is SARS-CoV-2 Spike glycoprotein impairing macrophage polarization via α7-nicotinic acetylcholine receptors?" |
Milad Shirvaliloo |
| 72 |
[GO] |
2021―Mar―31 |
Is SARS-CoV-2 Spike glycoprotein impairing macrophage polarization via α7-nicotinic acetylcholine receptors? |
Tanmay Saraiya, Dimitris Labrou, Konstantinos Farsalinos, Konstantinos Poulas |
| 73 |
[GO] |
2021―Mar―31 |
Review of: "Is SARS-CoV-2 Spike glycoprotein impairing macrophage polarization via α7-nicotinic acetylcholine receptors?" |
Juan Bautista De Sanctis |
| 74 |
[GO] |
2021―Mar―31 |
A Potential Therapy for SARS-Cov-2 Virus Deactivation: Carbon Dioxide Management |
yehya elsayed, Rania Shebair |
| 75 |
[GO] |
2021―Mar―31 |
A Potential Therapy for SARS-Cov-2 Virus Deactivation: Carbon Dioxide Management |
yehya elsayed, Rania Shebair |
| 76 |
[GO] |
2021―Mar―27 |
Review of: "Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR." |
Alessandro Poggi |
| 77 |
[GO] |
2021―Mar―24 |
Review of: "Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR." |
Konstantin Andreev |
| 78 |
[GO] |
2021―Mar―23 |
Review of: "Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR." |
Milad Shirvaliloo |
| 79 |
[GO] |
2021―Mar―20 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)" |
Omeed Memarsadeghi, MD, PhD |
| 80 |
[GO] |
2021―Mar―18 |
Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR. |
Tanmay Saraiya, Dimitris Labrou, Konstantinos Farsalinos, Konstantinos Poulas |
| 81 |
[GO] |
2021―Mar―18 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)" |
Jake Wen |
| 82 |
[GO] |
2021―Mar―17 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)" |
Seyedmohammadreza Heibati |
| 83 |
[GO] |
2021―Mar―16 |
Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR. |
Tanmay Saraiya, Konstantinos Farsalinos, Konstantinos Poulas, Dimitris Labrou |
| 84 |
[GO] |
2021―Mar―11 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)" |
Gour Goswami |
| 85 |
[GO] |
2021―Mar―10 |
Review of: "Successful Cessation Programs that Reduce Comorbidity may Explain Surprisingly Low Smoking Rates among Hospitalized COVID-19 Patients" |
Milad Shirvaliloo |
| 86 |
[GO] |
2021―Mar―09 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)" |
Luis del Carpio-Orantes |
| 87 |
[GO] |
2021―Mar―02 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 88 |
[GO] |
2021―Feb―17 |
Neuroinflammation links COVID-19 and fragile X syndrome: Role of MMP-9, IGF-1, IL-10, metformin, statins and curcumin |
Marcos Altable |
| 89 |
[GO] |
2021―Feb―17 |
Neuroinflammation links COVID-19 and fragile X syndrome: Role of MMP-9, IGF-1, IL-10, metformin, statins and curcumin |
Marcos Altable, Juan Moisés de la Serna |
| 90 |
[GO] |
2021―Feb―16 |
Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets |
Marcos Altable |
| 91 |
[GO] |
2021―Feb―16 |
Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets |
Marcos Altable, Juan Moisés de la Serna |
| 92 |
[GO] |
2021―Feb―14 |
Miglustat: A glycotransferase inhibitor for Covid-19 treatment |
Dean Tatlow |
| 93 |
[GO] |
2021―Feb―03 |
Miglustat: A glycotransferase inhibitor for Covid-19 treatment |
Dean Tatlow |
| 94 |
[GO] |
2021―Jan―30 |
Miglustat: A glycotransferase inhibitor for Covid-19 treatment |
Dean Tatlow |
| 95 |
[GO] |
2021―Jan―29 |
EFFECTIVENESS IN HUMANS OF AN ANTIVIRAL DRUG BASED ON CHOLINERGIC AGONISTS WITH SPECIFIC DESIGN AND ROUTE OF ADMINISTRATION AGAINST COVID-19 SYMPTOMS IN A GROUP OF INFECTED PATIENTS VS. CONTROL GROUP |
orlando Angulo, HECTOR FABIO RESTREPO, José Gabriel León Higuera, Mario Leon Garcia, Fernando Mendive, matteo politi |
| 96 |
[GO] |
2021―Jan―21 |
Miglustat: A glycotransferase inhibitor for Covid-19 treatment |
Dean Tatlow |
| 97 |
[GO] |
2021―Jan―14 |
Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: implications for public policies |
Roberto Sussman, Eliana Golberstein, Riccardo POLOSA |
| 98 |
[GO] |
2021―Jan―11 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 10) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 99 |
[GO] |
2020―Dec―30 |
Review of: "Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: implications for public policies" |
Andrés Lanzós |
| 100 |
[GO] |
2020―Dec―19 |
Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: implications for public policies |
Roberto Sussman, Eliana Golberstein, Riccardo POLOSA |
| 101 |
[GO] |
2020―Dec―19 |
Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: is it plausible? |
Roberto Sussman, Eliana Golberstein, Riccardo POLOSA |
| 102 |
[GO] |
2020―Dec―03 |
Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: is it plausible? |
Roberto Sussman, Eliana Golberstein, Riccardo POLOSA |
| 103 |
[GO] |
2020―Nov―26 |
Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: is it plausible? |
Roberto Sussman, Eliana Golberstein, Riccardo POLOSA |
| 104 |
[GO] |
2020―Nov―06 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 9) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 105 |
[GO] |
2020―Oct―07 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 8) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 106 |
[GO] |
2020―Oct―06 |
Mercury as a factor in COVID-19 mortality: hypothesis and evidence. |
Tim X Lee |
| 107 |
[GO] |
2020―Sep―15 |
E-cigarette use and COVID-19 in youth and young adults: serious questions about data reliability and call for retraction |
Konstantinos Farsalinos, Raymond Niaura |
| 108 |
[GO] |
2020―Sep―12 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7)" |
Peter Hajek |
| 109 |
[GO] |
2020―Sep―11 |
Record-breaker African Dust hits the Gulf Coast during the Covid-19 Pandemic |
Carlos Rodriguez |
| 110 |
[GO] |
2020―Sep―08 |
Bad Data and Bad Conclusions Will Lead to Bad Policy - Implausible Claims that Vaping Increases COVID-19 Risk for Youth and Young Adults |
Joe G. Gitchell, Bethea Kleykamp, Raymond Niaura, Saul Shiffman, K. Michael Cummings, David Sweanor, David Abrams |
| 111 |
[GO] |
2020―Sep―04 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 7) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 112 |
[GO] |
2020―Sep―01 |
Is Mercury Causing COVID-19 Deaths? |
Tim X Lee |
| 113 |
[GO] |
2020―Aug―30 |
Review of: "A Covid-19 death trail connecting the Mediterranean with the North Sea, Italy with England, through the Alps" |
Tim X Lee |
| 114 |
[GO] |
2020―Aug―30 |
Review of: "Gulf Stream gyres may have dictated the outcome of the Covid-19 disease in Western Europe" |
Tim X Lee |
| 115 |
[GO] |
2020―Aug―25 |
A Covid-19 death trail connecting the Mediterranean with the North Sea, Italy with England, through the Alps |
Carlos Rodriguez |
| 116 |
[GO] |
2020―Aug―24 |
A Covid-19 death trail connecting the Mediterranean with the North Sea, Italy with England, through the Alps |
Carlos Rodriguez |
| 117 |
[GO] |
2020―Aug―23 |
SETTING THE PRIORITIES RIGHT IN THE COVID-19 PANDEMIC |
Carlos Rodriguez |
| 118 |
[GO] |
2020―Aug―12 |
Gulf Stream gyres may have dictated the outcome of the Covid-19 disease in Western Europe |
Carlos Rodriguez |
| 119 |
[GO] |
2020―Aug―06 |
SETTING THE PRIORITIES RIGHT IN THE COVID-19 PANDEMIC |
Carlos Rodriguez |
| 120 |
[GO] |
2020―Aug―05 |
African or African American? That is the question.
The Duffy antigen and the Chemokine Storm in Covid-19 |
Carlos Rodriguez |
| 121 |
[GO] |
2020―Aug―02 |
Perspectives on the use of electrostimulation with the device “VEB”® in the management of disorders related to COVID-19 |
Walery Zukow |
| 122 |
[GO] |
2020―Aug―02 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 6) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 123 |
[GO] |
2020―Jul―12 |
Review of: "A nicotinic hypothesis for Covid-19 with
preventive and therapeutic implications" |
Steven Ubaldo Alvarez |
| 124 |
[GO] |
2020―Jul―05 |
African or African American? That is the question.
The Duffy antigen and the Chemokine Storm in Covid-19 |
Carlos Rodriguez |
| 125 |
[GO] |
2020―Jul―02 |
Vaping during the COVID-19 lockdown period in Belgium |
Karolien Adriaens, Dinska Van Gucht, Sven Van Lommel, Frank Baeyens |
| 126 |
[GO] |
2020―Jul―01 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 5) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 127 |
[GO] |
2020―Jun―30 |
COVID-19 Heavy Metal Hypothesis |
Tim X Lee |
| 128 |
[GO] |
2020―Jun―30 |
Vaping during the COVID-19 lockdown period in Belgium |
Karolien Adriaens, Dinska Van Gucht, Sven Van Lommel, Frank Baeyens |
| 129 |
[GO] |
2020―Jun―26 |
Good news from Alsace: the Covid-19 pandemic is (almost) over. NOW WHAT? |
Carlos Rodriguez |
| 130 |
[GO] |
2020―Jun―26 |
Review of: "Good news from Alsace: the Covid-19 pandemic is (almost) over. NOW WHAT?" |
jose nemesio Villarroel Rodriguez |
| 131 |
[GO] |
2020―Jun―26 |
Review of: "Good news from Alsace: the Covid-19 pandemic is (almost) over. NOW WHAT?" |
jose nemesio Villarroel Rodriguez |
| 132 |
[GO] |
2020―Jun―26 |
Review of: "Routes of transmission of SARS-CoV-2 and behaviours to block it: a summary" |
Sharon Cox |
| 133 |
[GO] |
2020―Jun―25 |
Neuropsychiatry and COVID-19: An Overview |
Marcos Altable, Juan Moisés de la Serna |
| 134 |
[GO] |
2020―Jun―24 |
Good news from Alsace: the Covid-19 pandemic is (almost) over. NOW WHAT? |
Carlos Rodriguez |
| 135 |
[GO] |
2020―Jun―23 |
Good news from Alsace: the Covid-19 pandemic is (almost) over. NOW WHAT? |
Carlos Rodriguez |
| 136 |
[GO] |
2020―Jun―17 |
A new exciting hypothesis: direct correlation between periodontitis and clinical evolution of COVID-19 patients. |
Giuseppina Campisi, Maria Eleonora Bizzoca, Lorenzo Lo Muzio |
| 137 |
[GO] |
2020―Jun―17 |
A new exciting hypothesis: direct correlation between periodontitis and clinical evolution of COVID-19 patients. Preprint. |
Giuseppina Campisi, Maria Eleonora Bizzoca, Lorenzo Lo Muzio |
| 138 |
[GO] |
2020―Jun―17 |
Journal Pre-proof: Cerebrovascular Disease in COVID-19: Is There a Higher Risk of Stroke? |
Marcos Altable |
| 139 |
[GO] |
2020―Jun―13 |
A new exciting hypothesis: direct correlation between periodontitis and clinical evolution of COVID-19 patients. |
Giuseppina Campisi, Maria Eleonora Bizzoca, LORENZO LO MUZIO |
| 140 |
[GO] |
2020―Jun―11 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 4) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 141 |
[GO] |
2020―Jun―02 |
Review of: "Successful Cessation Programs that Reduce Comorbidity may Explain Surprisingly Low Smoking Rates among Hospitalized COVID-19 Patients" |
Robert West |
| 142 |
[GO] |
2020―Jun―02 |
MDSCs IN COVID-19
Why should we care? |
Carlos Rodriguez |
| 143 |
[GO] |
2020―May―29 |
COVID-19 Heavy Metal Hypothesis |
Tim X Lee |
| 144 |
[GO] |
2020―May―29 |
Heavy Metal COVID-19 Hypothesis |
Tim X Lee |
| 145 |
[GO] |
2020―May―28 |
Review of: "Successful Cessation Programs that Reduce Comorbidity may Explain Surprisingly Low Smoking Rates among Hospitalized COVID-19 Patients" |
Joe G. Gitchell |
| 146 |
[GO] |
2020―May―28 |
The global helminth belt and Covid-19: the new eosinophilic link |
Carlos Rodriguez |
| 147 |
[GO] |
2020―May―27 |
Successful Cessation Programs that Reduce Comorbidity may Explain Surprisingly Low Smoking Rates among Hospitalized COVID-19 Patients |
Bruce Cohen, Aaron Nichols, Stephen Grant, Zack Blumenfeld, Dennis Dougherty, R. Michael Alvarez, et al. (+2) Beate Ritz, Henry Lester |
| 148 |
[GO] |
2020―May―27 |
The global helminth belt and Covid-19: the new eosinophilic link |
Carlos Rodriguez |
| 149 |
[GO] |
2020―May―25 |
Cerebrovascular Disease in COVID-19: Is There a Higher Risk of Stroke? |
Marcos Altable, Juan Moisés de la Serna |
| 150 |
[GO] |
2020―May―25 |
Cerebrovascular Disease in COVID-19: Is There a Higher Risk of Stroke? |
Marcos Altable, Juan Moisés de la Serna |
| 151 |
[GO] |
2020―May―23 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 3) |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 152 |
[GO] |
2020―May―19 |
Possible assistance of host microbiome in SARS-CoV-2 fitness |
Patrick SLAMA |
| 153 |
[GO] |
2020―May―17 |
Review of: "Child and Adult Autism Spectrum Disorder in COVID-19 Pandemic" |
Marcos Altable |
| 154 |
[GO] |
2020―May―17 |
Review of: "Perampanel, a novel neuroprotector and antiviral agent in COVID-19?" |
Susana Fuentes |
| 155 |
[GO] |
2020―May―17 |
Review of: "Perampanel, a novel neuroprotector and antiviral agent in COVID-19?" |
Susana Fuentes |
| 156 |
[GO] |
2020―May―14 |
Child and Adult Autism Spectrum Disorder in COVID-19 Pandemic |
Marcos Altable |
| 157 |
[GO] |
2020―May―11 |
Perampanel, a novel neuroprotector and antiviral agent in COVID-19? |
Marcos Altable |
| 158 |
[GO] |
2020―May―09 |
Low rate of daily active tobacco smoking in patients with symptomatic COVID-19 |
Makoto Miyara, Florence Tubach, Valérie POURCHER, Capucine Morelot-Panzini, Julie Pernet, Julien Haroche, et al. (+8) Said Lebbah, Elise Morawiec, Guy Gorochov, Eric Caumes, Pierre Hausfater, Alain COMBES, Thomas Similowski, Zahir Amoura |
| 159 |
[GO] |
2020―May―06 |
Possible assistance of host microbiome in SARS-CoV-2 fitness |
Patrick SLAMA |
| 160 |
[GO] |
2020―May―02 |
COVID-19 Heavy Metal Hypothesis |
Tim X Lee |
| 161 |
[GO] |
2020―May―02 |
Review of: "A nicotinic hypothesis for Covid-19 with
preventive and therapeutic implications" |
maysam fadaeikenarsary |
| 162 |
[GO] |
2020―May―02 |
Covid-19: A fecal-orally transmitted disease with severe involvement of the lungs |
Carlos Rodriguez |
| 163 |
[GO] |
2020―May―01 |
Review of: "A nicotinic hypothesis for Covid-19 with
preventive and therapeutic implications" |
Kristen Grad |
| 164 |
[GO] |
2020―Apr―30 |
A contribution to the hypothesis of nicotinic challenge as therapeutic option for COVID-19 patients |
Luigi Manni, Paolo Tieri, Marzia Soligo |
| 165 |
[GO] |
2020―Apr―30 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Carlos Rodriguez |
| 166 |
[GO] |
2020―Apr―29 |
Review of: "Smoking, vaping and hospitalization for COVID-19" |
Carlos Rodriguez |
| 167 |
[GO] |
2020―Apr―27 |
A contribution to the hypothesis of nicotinic challenge as therapeutic option for COVID-19 patients |
Luigi Manni, Paolo Tieri, Marzia Soligo |
| 168 |
[GO] |
2020―Apr―27 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Anna Gilmore |
| 169 |
[GO] |
2020―Apr―27 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Philip Wise |
| 170 |
[GO] |
2020―Apr―27 |
ASTHMA AND COVID-19: THE EOSINOPHILIC LINK |
Carlos Rodriguez, Carlos Veciana |
| 171 |
[GO] |
2020―Apr―27 |
Routes of transmission of SARS-CoV-2 and behaviours to block it: a summary |
Robert West, Susan Michie |
| 172 |
[GO] |
2020―Apr―26 |
COVID-19, a disease of the nicotinic cholinergic system? Nicotine may be protective |
Konstantinos Farsalinos, Raymond Niaura, Konstantinos Poulas |
| 173 |
[GO] |
2020―Apr―26 |
COVID-19, a disease of the nicotinic cholinergic system? Nicotine may be protective |
Konstantinos Farsalinos, Raymond Niaura, Konstantinos Poulas |
| 174 |
[GO] |
2020―Apr―25 |
A contribution to the hypothesis of nicotinic challenge as therapeutic option for COVID-19 patients |
Luigi Manni, Paolo Tieri, Marzia Soligo |
| 175 |
[GO] |
2020―Apr―23 |
Review of: "A nicotinic hypothesis for Covid-19 with
preventive and therapeutic implications" |
Philippe Girard |
| 176 |
[GO] |
2020―Apr―23 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 177 |
[GO] |
2020―Apr―23 |
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review |
David Simons, Lion Shahab, Jamie Brown, Olga Perski |
| 178 |
[GO] |
2020―Apr―23 |
Review of: "The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review" |
Peter Hajek |
| 179 |
[GO] |
2020―Apr―22 |
A nicotinic hypothesis for Covid-19 with
preventive and therapeutic implications |
jean-pierre CHANGEUX, Zahir Amoura, Felix Rey, Makoto Miyara |
| 180 |
[GO] |
2020―Apr―22 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Ivan Berlin |
| 181 |
[GO] |
2020―Apr―21 |
Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 |
Makoto Miyara, Florence Tubach, Valérie POURCHER, Capucine Morelot-Panzini, Julie Pernet, Julien Haroche, et al. (+8) Said Lebbah, Elise Morawiec, Guy Gorochov, Eric Caumes, Pierre Hausfater, Alain COMBES, Thomas Similowski, Zahir Amoura |
| 182 |
[GO] |
2020―Apr―21 |
A nicotinic hypothesis for Covid-19 with
preventive and therapeutic implications |
jean-pierre CHANGEUX, Zahir Amoura, Felix Rey, Makoto Miyara |
| 183 |
[GO] |
2020―Apr―21 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Jamie Brown |
| 184 |
[GO] |
2020―Apr―20 |
Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 |
Makoto Miyara, Florence Tubach, Valérie POURCHER, Capucine Morelot-Panzini, Julie Pernet, Julien Haroche, et al. (+8) Said Lebbah, Elise Morawiec, Guy Gorochov, Eric Caumes, Pierre Hausfater, Alain COMBES, Thomas Similowski, Zahir Amoura |
| 185 |
[GO] |
2020―Apr―20 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Konstantinos Farsalinos |
| 186 |
[GO] |
2020―Apr―20 |
Review of: "Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19" |
Konstantinos Farsalinos |
| 187 |
[GO] |
2020―Apr―19 |
Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 infection |
Makoto Miyara, Florence Tubach, Zahir Amoura |
| 188 |
[GO] |
2020―Apr―19 |
Review of: "Smoking, vaping and hospitalization for COVID-19" |
John Stapleton |
| 189 |
[GO] |
2020―Apr―19 |
Review of: "Smoking, vaping and hospitalization for COVID-19" |
Kevin Walker |
| 190 |
[GO] |
2020―Apr―12 |
Review of: "Smoking, vaping and hospitalization for COVID-19" |
Jason Sheltzer |
| 191 |
[GO] |
2020―Apr―08 |
Review of: "Smoking, vaping and hospitalization for COVID-19" |
Ivan Berlin |
| 192 |
[GO] |
2020―Apr―07 |
Review of "Smoking, vaping and hospitalization for COVID-19" |
George Laking |
| 193 |
[GO] |
2020―Apr―07 |
Routes of transmission of SARS-CoV-2 and behaviours to block it: a summary |
Robert West, Susan Michie |
| 194 |
[GO] |
2020―Apr―05 |
Review of "Smoking, vaping and hospitalization for COVID-19" |
Carl Phillips |
| 195 |
[GO] |
2020―Apr―04 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 196 |
[GO] |
2020―Apr―03 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 197 |
[GO] |
2020―Apr―03 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 198 |
[GO] |
2020―Apr―01 |
Smoking and COVID-19: Rapid evidence review for the Royal College of Physicians, London (UK) |
David Simons, Jamie Brown, Lion Shahab, Olga Perski |
| 199 |
[GO] |
2020―Mar―29 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 200 |
[GO] |
2020―Mar―29 |
Review of "Smoking, vaping and hospitalization for COVID-19" |
John Stapleton |
| 201 |
[GO] |
2020―Mar―28 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 202 |
[GO] |
2020―Mar―27 |
Review of "Smoking, vaping and hospitalization for COVID-19" |
Lion Shahab, Robert West, Jamie Brown |
| 203 |
[GO] |
2020―Mar―25 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 204 |
[GO] |
2020―Mar―25 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 205 |
[GO] |
2020―Mar―25 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 206 |
[GO] |
2020―Mar―25 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 207 |
[GO] |
2020―Mar―25 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 208 |
[GO] |
2020―Mar―24 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura |
| 209 |
[GO] |
2020―Mar―24 |
Review of "Smoking, vaping and hospitalization for COVID-19" |
Robert West |
| 210 |
[GO] |
2020―Mar―23 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, ANASTASIA BARBOUNI, Raymond Niaura |
| 211 |
[GO] |
2020―Mar―23 |
Smoking, vaping and hospitalization for COVID-19 |
Konstantinos Farsalinos, ANASTASIA BARBOUNI |
